Effect of policosanol on cerebral ischemia in Mongolian gerbils

Brazilian Journal of Medical and Biological Research

Volumn 32, Issue 10, 1999, Pages 1269-1276

  Molina, V ^a   Arruzazabala, M L ^a   Carbajal, D ^a   Valdes S ^a   Noa, M ^a   Mas R ^a   Fraga, V ^a   Menendez R ^a  

^a NATL CENTER FOR SCIENTIFIC RESEARCH   (Cuba)

Author keywords

Cerebral ischemia; Gerbils; Policosanol; Reperfusion brain edema

Indexed keywords

POLICOSANOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; FEMALE; GERBIL; HISTOPATHOLOGY; INTRAGASTRIC DRUG ADMINISTRATION; MORTALITY; NONHUMAN; ORAL DRUG ADMINISTRATION; TISSUE DISTRIBUTION;

EID: 0032701309     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X1999001000014     Document Type: Article

References (37)

1. Arruzazabala ML, Carbajal D, Más R, Molina V, Valdés S & Laguna A (1994). Cholesterol-lowering effects of policosanol in rabbits. Biological Research, 27: 205-208.
2. Menéndez R, Amor AM, González RM, Fraga V & Más R (1996). Effect of policosanol on the hepatic cholesterol biosynthesis of normocholesterolemic rats. Biological Research, 29: 253-257.
3. Menéndez R, Arruzazabala ML, Más R, del Río A, Amor AM, González RM, Carbajal D, Fraga V, Molina V & Illnait J (1997). Cholesterol-lowering effect of policosanol on rabbits with hypercholesterolemia induced by a wheat starch-casein diet. British Journal of Nutrition, 77: 923-932.
4. Hernández F, Illnait J, Más R, Castaño G, Fernández L, Gonzalez M, Cordovi N & Fernández J (1992). Effect of Ateromixol (policosanol) on serum lipids and lipoproteins in healthy volunteers. Current Therapeutic Research, 51: 1-8.
5. Aneiros E, Mas R, Calderón B, Illnait J, Fernández L, Castaño G & Fernández JC (1995). Effect of policosanol in lowering cholesterol levels in patients with type II hypercholesterolemia. Current Therapeutic Research, 56: 296-304.
6. Castano G, Más R, Nodarse M, Illnait J, Fernández L & Fernández JC (1995). One-year study of the efficacy and safety of policosanol (5 mg twice daily) in the treatment of type II hypercholesterolemia. Current Therapeutic Research, 56: 296-304.
7. Canetti M, Morera M, Illnait J, Más R, Fernández L, Castaño G & Fernández JC (1995). One year study on the effect of policosanol (5 mg-twice-a-day) on lipid profile in patients with type II hypercholesterolemia. Advances in Therapy, 12: 245-254.
8. Benítez M, Romero C, Más R, Fernández L & Fernàndez JC (1997). A comparative study of policosanol versus pravastatin in patients with type II hypercholesterolemia. Current Therapeutic Research, 58: 859-867.
9. Arruzazabala ML, Carbajal D, Más R, Garcia M & Fraga V (1993). Effect of policosanol on platelet aggregation in rats. Thrombosis Research, 69: 321-327.
10. Arruzazabala ML, Carbajal D, Molina V, Valdés S, Más R & García M (1992). Estudio farmacológico de la interacción del policosanol y la aspirina en animales de experimentación. Revista Iberoaméricana de Trombosis y Hemostasis, 5: 17-20.
11. Valdés S, Arruzazabala ML, Carbajal D, Más R, Fernández L & Molina V (1996). Effects of policosanol on platelet aggregation in healthy volunteers. International Journal of Clinical Pharmacology Research, XVI: 67-72.
12. Arruzazabala ML, Valdés S, Más R, Fernández L & Carbajal D (1996). Effect of policosanol successive dose increases on platelet aggregation in healthy volunteers. Pharmacological Research, 34: 181-185.
13. Carbajal D, Arruzazabala ML, Valdés S & Más R (1998). Effect of policosanol on platelet aggregation and serum levels of arachidonic acid metabolites in healthy volunteers. Prostaglandins, Leukotrienes and Essential Fatty Acids, 58: 61-64.
14. Levine S & Payan H (1966). Effects of ischemia and other procedures on the brain and retina of the gerbil (Meriones unguiculatus) Experimental Neurology, 16: 255-262.
15. Berry K, Wisniewski HM, Svarzbein L & Baez S (1975). On the relationship of brain vasculature to production of neurological deficit and morphological changes following acute unilateral common carotid artery ligation in gerbils. Journal of Neurological Sciences, 25: 75-92.
16. Arruzazabala ML, Carbajal D, Molina V, Valdés S & Más R (1993). Effect of policosanol on cerebral ischemia in Mongolian gerbils: Role of prostacyclin and thromboxane A. Prostaglandins, Leukotrienes and Essential Fatty Acids, 49: 695-697.
17. Taylor MD, Palmer GC & Callahan AS 11984). Protective action by methylprednisolone, allopurinol and indomethacin against stroke-induced damage to adenylate cyclase in gerbil cerebral cortex. Stroke, 15: 329-335.
18. Plum F, Posner J & Alond E (1963). Edema and necrosis in experimental cerebral infarction. Archives of Neurology, 9: 563-570.
19. Payan HM & Conard JR (1977). Carotid ligation in gerbil. Stroke, 8: 194-196.
20. Harrison MJG, Brownhill D, Lewis PD & Russell RWR (1973). Cerebral edema following carotid artery ligation in the gerbil. Archives of Neurology, 28: 389-391.
21. Schmidt-Kastner R & Freud T (1991). Selective vulnerability of the hippocampus in brain ischemia. Neuroscience, 40: 599-636.
22. Sims NR & Zaidan E (1995). Biochemical changes associated with selective neuronal death following short-term cerebral ischemia. International Journal of Biochemistry and Cellular Biology, 27: 531-550.
23. Christie-Pope BC, Palmer G, Chronister RB & Callahan A (1985). Adenylate cyclase and histopathological changes in the gerbil brain following prolonged unilateral ischemia and recirculation. Stroke, 16: 710-717.
24. Shah AB, Beamer N & Coull B (1985). Enhanced in vivo platelet activation in subtypes of ischemic stroke. Stroke, 16: 643 (Abstract).
25. 2 and prostacyclin. Pharmacological Reviews, 30: 293-331.
26. Carbajal D, Arruzazabala ML, Más R, Molina V & Valdés S (1994). Effect of policosanol on experimental thrombosis models. Prostaglandins, Leukotrienes and Essential Fatty Acids, 50: 249-251.
27. Siesjo BK (1981). Cell damage in the brain: a speculative synthesis Journal of Cerebral Blood Flow and Metabolism, 12: 155-185.
28. Tamura A, Yamamoto M, Shimizu M, Kirino T & Sano K (1985). Behavioral change after local cerebral ischemia in the rat. Journal of Cerebral Blood Flow and Metabolism, 5 (Suppl 1): s379 (Abstract).
29. Conger JD & Weil JV (1995). Abnormal vascular function following ischemia-reperfusion injury. Journal of Investigations in Medicine, 43: 431-442.
30. Schwartz JP, Mrsulja BJ, Passoneau JV & Klatzo L (1984). Alterations of cyclic nucleotide-related enzymes and ATPase during unilateral ischemia and recirculation in gerbil cerebral cortex Journal of Neurochemistry, 27: 101-107.
31. Raichle ME (1983). The pathophysiology of brain ischemia. Annals of Neurology, 13: 2-10.
32. Pickard JD (1981). Role of prostaglandins and arachidonic acid derivatives in the coupling of cerebral blood flow to cerebral metabolism. Journal of Cerebral Blood Flow and Metabolism, 1: 361-384.
33. Oliver CN, Starke-Reed PE, Stadtman ER, Liu GJ, Carney JM & Floyd RA (1990). Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia reperfusion-induced injury to gerbil brain. Proceedings of the National Academy of Sciences, USA, 87: 5144-5147.
34. Yoshida S, Inoh S, Asano T, Sano K, Kubota M, Shimazaki H & Ueta N (1980). Effect of transient ischemia on free fatty acids and phospholipids in the gerbil brain. Lipid peroxidation as a possible cause of postischemic injury. Journal of Neurosurgery, 53: 323-331.
35. Phillis JW, Perkins LM, Smith-Barbour M & O'Reagan MH (1995). Oxypurinol-enhanced postischemic recovery of the rat brain involves preservation of adenine nucleotides. Journal of Neurochemistry, 64: 2177-2184.
36. Himori N, Suzuki T & Ueno KI (1995). Aniracetam, a pyrrolidone-type cognition enhancer, attenuates the hydroxyl free radical formation in the brain of mice with brain ischemia. Journal of Pharmacy and Pharmacology, 47: 253-258.
37. Fraga V, Menéndez R, Amor AM, González RM, Jimenez S & Más R (1997). Effect of policosanol on in vitro and in vivo rat liver microsomal lipid peroxidation. Archives of Medical Research, 28: 355-360.